Valuation : EMVision Medical Devices Ltd

Market Cap 163M 117M 101M 95.08M 86.63M 162M 11.05B 1.13B 437M 5.65B 439M 430M 18.56B P/E 2027 *
-15.5x
P/E 2028 * -13.5x
Enterprise Value 163M 117M 101M 95.08M 86.63M 162M 11.05B 1.13B 437M 5.65B 439M 430M 18.56B EV / Sales 2027 *
32.6x
EV / Sales 2028 * 19.2x
Free-Float
66.78%
Yield 2027 *
-
Yield 2028 * -
1 day+1.45%
1 week-2.50%
Current month+2.63%
1 month+10.03%
3 months+2.03%
6 months-0.57%
Current year-1.40%
1 week 1.64
Extreme 1.635
1.77
1 month 1.52
Extreme 1.515
1.86
Current year 1.47
Extreme 1.47
1.96
1 year 1.47
Extreme 1.47
2.43
3 years 1.44
Extreme 1.445
2.72
5 years 1.13
Extreme 1.13
3.35
10 years 0.28
Extreme 0.28
4.2
Manager TitleAgeSince
Chief Executive Officer - 01/07/2023
Director of Finance/CFO - 01/02/2026
Chief Tech/Sci/R&D Officer - 01/07/2023
Director TitleAgeSince
Chairman - -
Director/Board Member - -
Director/Board Member - 01/07/2018
Date Insider Type Main position Quantity % Market Cap. Importance
23/4/26 Buy

Director

10,000 0.0108%
2/1/26 Expiration

Chairman

300,000 0.3228%
18/11/25 Free

Director

200,000 0.2176%
Change 5-day change 1-year change 3-year change Capi.($)
+1.45%-2.50%-11.36%+3.24% 115M
+1.18%-4.36%+24.31%+11.82% 222B
+1.67%-2.49%+3.05%-19.49% 145B
+0.31%+0.21%-20.86%+20.65% 130B
+2.01%+2.48%-53.72%-7.38% 69.68B
+0.50%+0.48%+11.55%+20.07% 52.3B
+0.41%+0.51%-14.70%-13.41% 50.71B
+1.15%-2.45%+20.82%+27.42% 42.28B
+1.46%-0.88%+38.47%+48.55% 39.87B
+1.00%-1.08%-14.08%+51.31% 33.37B
Average +1.12%-1.50%-1.65%+14.28% 78.63B
Weighted average by Cap. +1.13%-1.58%+1.50%+9.09%

Financials

2027 *2028 *
Net sales 5M 3.59M 3.09M 2.91M 2.66M 4.96M 339M 34.5M 13.39M 173M 13.46M 13.17M 569M 8.5M 6.1M 5.26M 4.95M 4.51M 8.44M 576M 58.65M 22.76M 294M 22.89M 22.39M 967M
Net income -12M -8.61M -7.42M -6.99M -6.37M -11.91M -813M -82.8M -32.13M -416M -32.32M -31.61M -1.37B -14.5M -10.4M -8.97M -8.45M -7.7M -14.39M -982M -100M -38.83M -502M -39.05M -38.19M -1.65B
Net Debt - -
Logo EMVision Medical Devices Ltd
EMVision Medical Devices Limited is an Australian medical device company. The Company is focused on the development and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, as well as other medical imaging needs. The Company’s primary focus is portable and non-invasive brain scanners, including a bedside device (emu) and an ultra-light weight pre-hospital device (First Responder). Its first indication is in stroke care. Its product pipeline includes portable and non-invasive brain scanners, including a bedside device (emu) and a light weight first responder pre-hospital device. Its First Responder Brain Scanner device is an ultra-light weight device embedded in standard road and air ambulances to deliver pre-hospital stroke diagnosis and care to patients regardless of location. The emu Brain Scanner device detects clinically significant changes, at the bedside, when time matters.
Employees
-
Date Price Change Volume
02/09/26 $1.755 +1.45% 43,211
01/09/26 $1.730 +1.17% 27,241
31/08/26 $1.710 +2.40% 48,759
28/08/26 $1.670 -3.19% 38,008
27/08/26 $1.725 0.00% 12,846
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
1.755AUD
Average target price
3.150AUD
Spread / Average Target
+79.49%

Annual profits - Rate of surprise